Showing results (111-120 of 124) with videos related to
Sort By:
Pageof 13
Spine|October 9, 2025
Beyond the ODI: Qualitative Factors That Contribute to Patient Satisfaction After Lumbar Surgery Despite Failure to Achieve MCID or PASSEric R Zhao, Nishtha Singh, Tejas Subramanian, et al.International Journal of Radiation Oncology, Biology, Physics|February 8, 2018
Prospective, Multicenter, Phase 2 Trial of Induction Chemotherapy Followed by Bio-Chemoradiotherapy for Locally Advanced Recurrent Nasopharyngeal CarcinomaWai-Tong Ng, Roger K C Ngan, Dora L W Kwong, et al.Cancer|June 30, 2017
A multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10-year outcomes for efficacy and toxicityAnne W M Lee, Stewart Y Tung, Wai Tong Ng, et al.The Spine Journal : Official Journal of the North American Spine Society|October 17, 2025
Quantifying cumulative postoperative disability after lumbar spine surgery with spline-based modified integrated health stateTomoyuki Asada, Adrian T H Lui, Adin M Ehrlich, et al.Clinical Spine Surgery|May 25, 2026
Temporal Trends of Recovery in Patients With Radiculopathy-Only Versus Myelopathy Following Single- and Multilevel ACDFEric R Zhao, Pratyush Shahi, Jung Kee Mok, et al.Neurosurgery|February 4, 2026
Modified Integrated Health State Suggests Lower Cumulative Neck Pain-Related Disability After Cervical Disk Replacement Compared With Anterior Cervical Diskectomy and FusionTomoyuki Asada, Adin M Ehrlich, Sereen Halayqeh, et al.Journal of Clinical Medicine|July 12, 2025
Time Course of Functional Recovery Following Single-Level Anterior Lumbar Interbody Fusion with and Without Posterior Instrumentation: A Retrospective Single-Institution StudyTejas Subramanian, Stephane Owusu-Sarpong, Sophie Kush, et al.Cancer|December 23, 2014
Preliminary results of trial NPC-0501 evaluating the therapeutic gain by changing from concurrent-adjuvant to induction-concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinomaAnne W M Lee, Roger K C Ngan, Stewart Y Tung, et al.European Journal of Cancer (Oxford, England : 1990)|November 30, 2010
Factors contributing to the efficacy of concurrent-adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: combined analyses of NPC-9901 and NPC-9902 TrialsAnne W M Lee, Stewart Y Tung, Roger K C Ngan, et al.International Journal of Radiation Oncology, Biology, Physics|June 11, 2018
Concurrent-Adjuvant Chemoradiation Therapy for Stage III-IVB Nasopharyngeal Carcinoma-Exploration for Achieving Optimal 10-Year Therapeutic RatioWai-Tong Ng, Stewart Y Tung, Victor Lee, et al.Pageof 13